Dr Craig Newman
Profiles

Dr Craig Newman

Senior Research Fellow

Clinical Trials & Health Research - Institute of Translational & Stratified Medicine (Faculty of Medicine and Dentistry)

Role

·     Senior Research Fellow (PUPSMD)

·     Mobile Health TechnologyInnovations Lead (PUPSMD)

·     Group Lead - Neuro-CognitiveResearch Centre (www.neurocore.org.uk)

·     NHS Innovation Accelerator Fellow (NHSEngland)

·     Principal Clinical Psychologist  (Derriford Hospital,Plymouth, Neuropsychology)

·     Associate PsychologyLecturer(Plymouth University)

o   Neuropsychology

o   Professional Skills(Innovation beyond clinical practice)

o   Research Skills


Qualifications

  • BSc Hons Psychology - Stirling University (2000)
  • PhD - Behavioural Economics and Addition - Keele University (2008)
    Assessment and adjustment of decision making impairment in heroin addicts, via a
    software based simulated decision making intervention.
  • DClinPsych - Plymouth University (2012)
    Assessment of executive functioning, in dementia, via a mobile tablet based translation of the Trail Making Test. 


Specialisms:

·     Computerised cognitiveassessment

·     Clinical softwarearchitecture

·     Usability research

·     Digital eHealthinnovations project management

Professional membership

Health Professionals Counsel

Chartered Clinical Psychologist (BPS)

Division of Clinical Psychology (CPsychol)

Teaching interests

  • Clinical Neuropsychology (MPsych & DClin)
  • Professional practice (DClin)
  • Clinical research skills (DClin)
  • Psychology of participation (clinical trials) (NHS Research Nurses)

Research interests

The development and implementation of:

  1. computerised applicationswhich support cognitive assessment, clinical assessment and self-assessment ofneurodegenerative conditions.
  2. computerised patient self-management apps - self-monitoring, self-triage and treatment triggering systems.  

Current studies (click link)

Current software development (click link)

Key publications are highlighted

Journals
Articles
Shankar R, Newman C, Gales A, McLean BN, Hanna J, Ashby S, Walker MC & Sander JW 2018 'Has the Time Come to Stratify and Score SUDEP Risk to Inform People With Epilepsy of Their Changes in Safety?' FRONTIERS IN NEUROLOGY 9, Author Site , DOI PEARL
Shankar R, Henley W, Boland C, Laugharne R, McLean BN, Newman C, Hanna J, Ashby S, Walker MC & Sander JW 2018 'Decreasing the risk of sudden unexpected death in epilepsy: structured communication of risk factors for premature mortality in people with epilepsy' European Journal of Neurology Author Site , DOI PEARL
Page R, Shankar R, McLean BN, Hanna J & Newman C 2018 'Digital Care in Epilepsy: A Conceptual Framework for Technological Therapies' FRONTIERS IN NEUROLOGY 9, Author Site , DOI PEARL
Newman CGJ, Bevins AD, Zajicek JP, Hodges JR, Vuillermoz E, Dickenson JM, Kelly DS, Brown S & Noad RF 2018 'Improving the quality of cognitive screening assessments: ACEmobile, an iPad-based version of the Addenbrooke's Cognitive Examination-III' Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 10, 182-187 , DOI PEARL
Mclean B, Shankar R, Hanna J, Jory C & Newman C 2017 'Sudden unexpected death in epilepsy: measures to reduce risk' Practical Neurology 17, (1) 13-20 , DOI PEARL
Shankar R, Walker M, McLean B, Laugharne R, Ferrand F, Hanna J & Newman C 2016 'Steps to prevent SUDEP: the validity of risk factors in the SUDEP and seizure safety checklist: a case control study' Journal of Neurology 263, (9) 1840-1846 , DOI PEARL
Jory C, Shankar R, Coker D, McLean B, Hanna J & Newman C 2016 'Safe and sound? A systematic literature review of seizure detection methods for personal use' Seizure 36, 4-15 , DOI
Newman C, Shankar R, Hanna J, McLean B, Osland A, Milligan C, Ball A, Jory C & Walker M 2016 'Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market' JMIR Research Protocols 5, (2) e82-e82 , DOI
Shankar R, Newman C, McLean B, Anderson T & OBE JH 2015 'Can technology help reduce risk of harm in patients with epilepsy?' British Journal of General Practice 65, (638) 448-449 , DOI
Shankar R, Newman C, Hanna J, ashton J, Jory C, McLean B, Anderson T, Walker M, cox D & Ewins L 2015 'Keeping patients with epilepsy safe: a surmountable challenge?' BMJ Quality Improvement Reports 4, (1) u208167.w3252-u208167.w3252 , DOI
Brown H, Newman C, Noad R & Weatherby S 2012 'Behavioural management of migraine' Ann Indian Acad Neurol 15, (Suppl 1) S78-S82 Author Site , DOI
Briazu R, Newman C, Noad R & Pearson S 2011 'An investigation into the use of computerised technology for the assessment of hand motor impairment in Alzheimer's disease' INTERNATIONAL PSYCHOGERIATRICS 23, Author Site
Newman CGJ, Crome I & Frisher M 2009 'S64-01 Revealing the role of context, experience and individual differences in the assessment of heroin addicts’ decision making abilities' European Psychiatry 24, S305-S305 , DOI
Newman CGJ, Crome I & Frisher M 2007 'The impact of feedback and punishment on the decisions of male heroin addicts' European Psychiatry 22, S194-S195 , DOI
Newman C & Adams K 2004 'Dog Gone Good: managing dog phobia in a teenage boy with a learning disability' British Journal of Learning Disabilities 32, (1) 35-38 , DOI
Bruce V, Ness H, Hancock PJB, Newman C & Rarity J 2002 'Four heads are better than one: Combining face composites yields improvements in face likeness' Journal of Applied Psychology 87, (5) 894-902 , DOI
Newman CF 0 'Showing up for your own life: Cognitive therapy of avoidant personality disorder' In Session: Psychotherapy in Practice 4, (4) 55-71 , DOI
Conference Papers
Dominey T, Newman C, Carroll C, Noad R, Appleyard B, Deeprose C & Hall S 2016 'PD-TAP: AN OBJECTIVE AND AUTOMATED MEASURE OF PARKINSON'S DISEASE SEVERITY' e1.237-e1 , DOI
Noad R, Newman C, Carroll C & Zajicek J 2015 'iPAD-BASED ASSESSMENT IN PARKINSON'S DISEASE' e4.189-e4 , DOI
Shankar R, Hanna J, McLean B, Cox D, Jory C, Newman C, Anderson T & Walker M 2015 'THE SUDEP SAFETY CHECKLIST LIST PROJECT: STEPS TOWARDS SELF-MANAGEMENT OF SUDEP RISK FOR PATIENTS WITH EPILEPSY (PWE)' 38-39